These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 30054337)

  • 1. Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma.
    Mair R; Wright AJ; Ros S; Hu DE; Booth T; Kreis F; Rao J; Watts C; Brindle KM
    Cancer Res; 2018 Sep; 78(18):5408-5418. PubMed ID: 30054337
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
    Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
    Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deuterium Metabolic Imaging Differentiates Glioblastoma Metabolic Subtypes and Detects Early Response to Chemoradiotherapy.
    Low JCM; Cao J; Hesse F; Wright AJ; Tsyben A; Alshamleh I; Mair R; Brindle KM
    Cancer Res; 2024 Jun; 84(12):1996-2008. PubMed ID: 38635885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KPNA2 promotes metabolic reprogramming in glioblastomas by regulation of c-myc.
    Li J; Liu Q; Liu Z; Xia Q; Zhang Z; Zhang R; Gao T; Gu G; Wang Y; Wang D; Chen X; Yang Y; He D; Xin T
    J Exp Clin Cancer Res; 2018 Aug; 37(1):194. PubMed ID: 30115078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
    Tateishi K; Iafrate AJ; Ho Q; Curry WT; Batchelor TT; Flaherty KT; Onozato ML; Lelic N; Sundaram S; Cahill DP; Chi AS; Wakimoto H
    Clin Cancer Res; 2016 Sep; 22(17):4452-65. PubMed ID: 27076630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.
    Chaumeil MM; Ozawa T; Park I; Scott K; James CD; Nelson SJ; Ronen SM
    Neuroimage; 2012 Jan; 59(1):193-201. PubMed ID: 21807103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDAC inhibition in glioblastoma monitored by hyperpolarized
    Radoul M; Najac C; Viswanath P; Mukherjee J; Kelly M; Gillespie AM; Chaumeil MM; Eriksson P; Delos Santos R; Pieper RO; Ronen SM
    NMR Biomed; 2019 Feb; 32(2):e4044. PubMed ID: 30561869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.
    Radoul M; Chaumeil MM; Eriksson P; Wang AS; Phillips JJ; Ronen SM
    Mol Cancer Ther; 2016 May; 15(5):1113-22. PubMed ID: 26883274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma.
    Park I; Lupo JM; Nelson SJ
    Mol Imaging Biol; 2019 Aug; 21(4):626-632. PubMed ID: 30225760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of metabolic change in glioblastoma cells after radiotherapy using hyperpolarized
    Kawai T; Brender JR; Lee JA; Kramp T; Kishimoto S; Krishna MC; Tofilon P; Camphausen KA
    NMR Biomed; 2021 Jul; 34(7):e4514. PubMed ID: 33939204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer recurrence monitoring using hyperpolarized [1-
    Shin PJ; Zhu Z; Camarda R; Bok RA; Zhou AY; Kurhanewicz J; Goga A; Vigneron DB
    Magn Reson Imaging; 2017 Nov; 43():105-109. PubMed ID: 28716678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperpolarized [1-
    Scroggins BT; Matsuo M; White AO; Saito K; Munasinghe JP; Sourbier C; Yamamoto K; Diaz V; Takakusagi Y; Ichikawa K; Mitchell JB; Krishna MC; Citrin DE
    Clin Cancer Res; 2018 Jul; 24(13):3137-3148. PubMed ID: 29599412
    [No Abstract]   [Full Text] [Related]  

  • 13. Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-
    Zaccagna F; McLean MA; Grist JT; Kaggie J; Mair R; Riemer F; Woitek R; Gill AB; Deen S; Daniels CJ; Ursprung S; Schulte RF; Allinson K; Chhabra A; Laurent MC; Locke M; Frary A; Hilborne S; Patterson I; Carmo BD; Slough R; Wilkinson I; Basu B; Wason J; Gillard JH; Matys T; Watts C; Price SJ; Santarius T; Graves MJ; Jefferies S; Brindle KM; Gallagher FA
    Radiol Imaging Cancer; 2022 Jul; 4(4):e210076. PubMed ID: 35838532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperpolarized Pyruvate MR Spectroscopy Depicts Glycolytic Inhibition in a Mouse Model of Glioma.
    Michel KA; Zieliński R; Walker CM; Le Roux L; Priebe W; Bankson JA; Schellingerhout D
    Radiology; 2019 Oct; 293(1):168-173. PubMed ID: 31385757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detecting response of rat C6 glioma tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic resonance spectroscopic imaging.
    Day SE; Kettunen MI; Cherukuri MK; Mitchell JB; Lizak MJ; Morris HD; Matsumoto S; Koretsky AP; Brindle KM
    Magn Reson Med; 2011 Feb; 65(2):557-63. PubMed ID: 21264939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperpolarized
    Bliemsrieder E; Kaissis G; Grashei M; Topping G; Altomonte J; Hundshammer C; Lohöfer F; Heid I; Keim D; Gebrekidan S; Trajkovic-Arsic M; Winkelkotte AM; Steiger K; Nawroth R; Siveke J; Schwaiger M; Makowski M; Schilling F; Braren R
    Sci Rep; 2021 Jan; 11(1):1191. PubMed ID: 33441943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 13C-pyruvate imaging reveals alterations in glycolysis that precede c-Myc-induced tumor formation and regression.
    Hu S; Balakrishnan A; Bok RA; Anderton B; Larson PE; Nelson SJ; Kurhanewicz J; Vigneron DB; Goga A
    Cell Metab; 2011 Jul; 14(1):131-42. PubMed ID: 21723511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bevacizumab treatment induces metabolic adaptation toward anaerobic metabolism in glioblastomas.
    Fack F; Espedal H; Keunen O; Golebiewska A; Obad N; Harter PN; Mittelbronn M; Bähr O; Weyerbrock A; Stuhr L; Miletic H; Sakariassen PØ; Stieber D; Rygh CB; Lund-Johansen M; Zheng L; Gottlieb E; Niclou SP; Bjerkvig R
    Acta Neuropathol; 2015 Jan; 129(1):115-31. PubMed ID: 25322816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging breast cancer using hyperpolarized carbon-13 MRI.
    Gallagher FA; Woitek R; McLean MA; Gill AB; Manzano Garcia R; Provenzano E; Riemer F; Kaggie J; Chhabra A; Ursprung S; Grist JT; Daniels CJ; Zaccagna F; Laurent MC; Locke M; Hilborne S; Frary A; Torheim T; Boursnell C; Schiller A; Patterson I; Slough R; Carmo B; Kane J; Biggs H; Harrison E; Deen SS; Patterson A; Lanz T; Kingsbury Z; Ross M; Basu B; Baird R; Lomas DJ; Sala E; Wason J; Rueda OM; Chin SF; Wilkinson IB; Graves MJ; Abraham JE; Gilbert FJ; Caldas C; Brindle KM
    Proc Natl Acad Sci U S A; 2020 Jan; 117(4):2092-2098. PubMed ID: 31964840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
    Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
    J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.